English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

1 Senior Resident, Sukh Sagar Medical College, Jabalpur 2 Consultant, Marble City Hospital, Jabalpur 3 Assistant Professor, Sukh Sagar Medical College, Jabalpur *Corresponding Author Dr Sadiya Hussain Assistant Professor, Sukh Sagar Medical College, Jabalpur, MP, India Abstract A randomized controlled study was conducted at such sagar medical college, Jabalpur for comparative analysis of topical cyclosporine (0.05%) and olopatadine (0.2%) in patients of vernal keratoconjuctivitis. Total number of patients specified for study was 62 among which 30 patients received cyclosporine and 32 received olopatadine. Improvement in signs and symptoms was assessed for a period of one month. As a result both treatment modalities were found to be safe and effective in treating VKC. In 1 st week Olopatadine was more effective but thereafter no statistically significant difference could be observed in their efficacy.

Controlled trial of cyclosporine (0.05%) versus Olopatadine (0.2%) topical solution in treatment of vernal keratoconjuntivitis